News
Makary announced plans for a new rare disease pathway in an April episode of "The Megyn Kelly Show." The proposal follows ...
Hosted on MSN1mon
AlphaFold opens new doors in drug development—how
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...
Morning Overview on MSN6d
The first AI-generated drug enters clinical trials
The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Generative AI, once seen as a tool for writers and artists, is now reshaping the high-stakes world of pharma regulation.
Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.
Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...
Six weeks after a reduction in force (RIF) at the US Food and Drug Administration removed thousands of workers, signs are emerging about how the agency’s approach to drug approval may change. The 20% ...
Southwest Research Institute scientists developed a new purification technique to improve chromatography results without expensive purification materials or equipment. Chromatography is an essential ...
Cancer drug in development at Ohio State could treat some of the most difficult forms of the illness
This weekend, thousands of riders will take to the streets for Pelotonia — the annual bike ride that raises millions of dollars for cancer research right here in Columbus. One of the projects ...
New Delhi, The Centre is set to amend the New Drugs and Clinical Trials Rules, 2019, that would halve the statutory time to process applications for test licenses to manufacture or use a new drug in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results